Abstract The naturally occurring second messenger sphingosine (SPH) was examined for its ability to influence cardiac myocyte Ca2' regulation. SPH inhibited intracellular Ca'+ transients in adult and neonatal rat ventricular myocytes. The inhibition was steeply dose dependent, with complete blockage of the Ca'+ transients occurring in the 20-to 25-,umol/L range.
S phingosine (SPH) is a putative second messenger that may participate in signal transduction through its ability to modulate various protein kinasesl-7 and phospholipases.8 '9 Recent studies using nonmuscle cells have demonstrated that SPH is also involved in protein kinase-independent signal transduction wherein SPH or its derivatives act on intracellular Ca 2 stores. For example, sphingolipids have been implicated in Ca2-dependent stimulus-secretion coupling,10-12 neutrophil activation,13'4 and cell proliferation.15-'9 A sphingolipid-gated Ca21 channel has recently been described for microsomes isolated from rat basophilic leukemia cells. 20 Further, SPH blocks depolarization-induced Ca 2 fluxes across brain synaptosomes, thus lowering cytoplasmic Ca2+. 12 Importantly, SPH and possibly its metabolite, SPH-1-phosphate (S1P), modulate Ca>2 release in permeabilized smooth muscle cells,21 implicating SPH as a regulator of Ca2-signaling pathways of both muscle and nonmuscle cells.
In striated muscle, excitation-contraction (EC) coupling involves the release of Ca 2+ through a channel in the sarcoplasmic reticulum (SR) membrane, which is referred to as the ryanodine receptor (RyR) because of its affinity for the plant alkaloid ryanodine. It is likely signaling, we examined the potential involvement of sphingolipids in regulating EC coupling of striated muscle cells.
SPH was previously shown to be capable of inhibiting Ca2' release from skinned skeletal muscle fibers and from isolated skeletal muscle SR membranes.26 SPH also reduces ['H]ryanodine binding to both skeletal and cardiac membranes containing the release channel, a result that is consistent with the blockage of the RyR channel by SPH.26, 27 We also observed that the threshold for CICR was shifted by SPH such that higher levels of "trigger" Ca21 were required to release Ca2+ from isolated cardiac microsomes containing the RyR.27 In chemically "skinned" adult rabbit cardiomyocytes lacking a functioning sarcolemma, SPH reduced the characteristic sarcomere activation waves without affecting contractile protein function. 28 Since CICR is responsible for the sarcomere activation waves in these cells, the SPH effect was interpreted as a putative action of SPH on the CICR mechanism of the SR.
Materials and Methods

Chemicals and Stock Solutions SPH [D(+)-erythro-2-amino-4-trans-octadecene-1,3-diol], sphingosylphosphorylcholine (SPC [lysosphingomyelin])
, and C2 ceramide (N-acetyl-D-SPH) were purchased from Matreya, Inc; indo 1-AM, fluo 3-AM, and the pentaammonium salt of fluo 3 were obtained from Molecular Probes; and H7 was obtained from Seikagaku. All other chemicals, including stearoyl ceramide (N-stearoyl-D-SPH), DL-erythro-dihydrosphingosine (eDHSPH), and DL-threo-dihydrosphingosine (tDHSPH) were obtained from Sigma Chemical Co.
For the isolated myocyte experiments, stock solutions of SPH and other sphingolipids were prepared as complexes with fatty acid-free bovine serum albumin (BSA)13 so that the compounds could be delivered in the absence of micelles and without substantial solvent present. In control experiments, the delivery vehicle, BSA, did not by itself have any effects on the L-type Ca2+ current (ICa) or on the Ca2+ transients. Lambeth et a113 have shown that the dose-response curves are similar when SPH is added either as "free SPH" or as a complex with BSA. The ceramide, N-stearoyl-D-SPH, was prepared as a x 40 chloroform: methanol (2:1) stock solution, which was dried down in N2 before being diluted and dispersed into the final incubation media by bath sonication. Generally, sphingolipid solutions (0.1 mL) were added directly to the recording chamber (1.0-mL capacity) from a x 10 stock solution containing BSA (direct-application method). In some experiments, sphingolipids were added by replacing the cell chamber contents by perfusion with 2.0 mL of the solution containing the final desired concentration of sphingolipid (slow perfusion method). The direct-application method yielded generally stronger effects than obtained by slow perfusion of the chamber but sometimes disturbed the gigaseals in patch-clamp experiments. The reason for the discrepancy is likely due to time-dependent differences in the amount of SPH initially seen by the cell under the two conditions. Unless otherwise indicated, results presented were obtained by the direct-application method.
Cell Preparation
Neonatal ventricular myocytes were dissociated and plated on fibronectin-coated glass coverslips in DMEM/F12 medium supplemented with 10% fetal calf serum (FCS) and antibiotics as previously described.29 After 24 hours in plating medium, the cells were rinsed and cultured for an additional 48 hours in medium containing 2% FCS.
Freshly dissociated adult ventricular myocytes were prepared from adult (200-to 350-g) Sprague-Dawley rat hearts by enzymatic dissociation as previously described.30 The Tyrode's solution used for cell isolation contained (mmol/L) NaCl 140, KCl 5.4, MgCl2 0. Patch-clamp recordings were performed in the presence of tetrodotoxin to block inward Na+ currents and by replacing intracellular K' with Cs+ in the pipette to block outwardly directed K' currents. Thus, at a holding potential of -50 mV, which inactivates T-type Ca 2+ channel activity, the currents recorded under voltage-clamp conditions represent current carried exclusively by Ca21 through the L-type channel. 1CaS were elicited and monitored by 70-millisecond depolarizing pulses to 0 mV every 10 seconds with a holding potential of -50 mV. Peak ICa was elicited at~=0 mV. During the monitoring of 1Ca for 5 minutes in the control condition, no significant rundown of 'Ca was observed (see Fig 6) .
Simultaneous Measurements of ICa and Fluo 3 Ca2' Transients
In a few experiments, adult myocytes were loaded with fluo 3 by 20-minute (room temperature) incubation in Tyrode's solution containing 4 ,umol/L fluo 3-AM. These cells were then patch-clamped as described above with 50 ,umol/L fluo 3 pentaammonium salt added to the pipette solution instead of the EGTA/Ca2+ specified above. Ca21 transients were recorded simultaneously with a Nikon Diaphot microscope interfaced to Oriel 77346 photomultiplier 77265 housing and 70705 photomultiplier power supply. Light from a 150-W xenon lamp was directed through a 485-nm excitation filter and reflected off a 505-nm dichroic mirror through a longworking x20 fluor objective (Nikon). The emitted light was collected through the same objective and dichroic mirror and filtered with a 530-nm bandpass filter (Omega Optical). The optical tracing was filtered at 500 Hz and sampled at 4 kHz. capable of rapidly (in 10 to 30 seconds) inhibiting the electrically evoked transients in both neonatal and adult cell preparations. The negative inotropic effect of SPH was independent of the type of myocyte used and was also present when several different bathing solutions and temperatures were used. For example, SPH inhibited intracellular Ca2' transients when recordings were carried out either in air-compatible DMEM or Tyrode's solution at both room temperature and at 37°C without appreciable differences in response (data not shown).
On the other hand, the myocytes were more sensitive to SPH when the agent was added by the direct-application method rather than by slow perfusion (see "Materials and Methods"). There were also some differences in the kinetics of SPH inhibition. For example, sometimes the transients diminished progressively before they were eliminated (as in Fig 1) , endogenous PKC levels were downregulated by 24 hours of pretreatment with 100 nmol/L phorbol 12,13-dibutyrate (PDBu) (Fig 4C) . This protocol lowers endogenous PKC activity levels by >85%.4' PKC-downregulated cells responded to SPH in a manner indistinguishable from that of control cells (Fig 4A) cultured for the same period but without the presence of PDBu. Finally, activation of PKC by acute (6.5-minute) PDBu (100 nmol/L) pretreatment did not alter the SPH-mediated inhibition of the transients (Fig 4D) .
Effects of SPH Analogues and Dihydrosphingosine
To demonstrate the specificity of the effect of SPH on myocyte transients, we tested the abilities of other SPH analogues to affect cardiac Ca2' transients. Fig 5A shows that 50 ,umol/L N-acetyl SPH (C2 ceramide) slightly reduced the transients but was unable to completely block the transients in a SPH-like manner. N-Acetyl SPH is a synthetic cell-permeant ceramide that differs from SPH by the acylation of its primary amine (refer to chemical structure on the figure) . The longer-chain-length naturally occurring ceramide, N-stearoyl-D-SPH, was even less able to reduce the magnitude of the Ca2' transients (Fig SB) Time (seconds) 25 50 Time (seconds Ca'+ transients suggests that SPH does not produce nonspecific membrane effects that might alter the parameters tested in the present study. The finding that DHSPH was =50% as effective as SPH in blocking the Ca 2 transients suggests that the presence of the double bond on the hydrocarbon tail of SPH is important but not critical in determining SPH function. Our data are similar to the finding that DHSPH stimulates SPHactivated protein kinase "50% as well as SPH itself.7 Since both the threo and erythro stereoisomers of DHSPH were effective in blocking the transients, the position of the third hydroxyl relative to the primary amine is not critical in determining SPH action.
In preliminary experiments, we have localized to T-tubule membranes the major enzyme responsible for sphingolipid synthesis, the neutral form of sphingomyelinase.26 Using high-performance liquid chromatography for analyses of isolated skeletal muscle membranes, 47 we have determined that T tubules and not SR membranes are a major source of endogenous SPH, suggesting that the complete metabolic machinery for SPH synthesis is likely in the T-tubule membranes. It is significant that ceramides like N-stearoyl-D-SPH, which are the immediate precursors of SPH, are not able to block either the Ca 2 transients or L-type channel conductances of cardiac myocytes, nor are the ceramides able to block SR Ca2' release in an SPH-like manner. Thus, although ceramides have important physiological actions in other cells (see Reference 50 for review), they do not appear to affect cardiac Ca2`. Also, it can be tentatively concluded that the SPH actions reported in the present study are not dependent on its enzymatic conversion to S1P. This conclusion is supported by the observations that (1) S1P does not block Ca>2 transients, (2) the effects of SPH on intact cell Ca 2 transients are nearly immediate and not temperature dependent in the 22°C to 37°C range (data not shown), and (3) SPH can block SR Ca' release in cell-free systems (presumably lacking the SPH kinase) and that action is immediate. 26, 27 The sphingomyelin signal transduction pathway has received much attention as a novel system involved in the activation of a variety of cell types, including EL4 thymoma cells,55 HL60 cells,56 and GH3 pituitary cells,57 and has been postulated to participate in NFKB transcription factor activation58 and apoptosis.59 Ceramide is considered the principle second messenger responsible for most of these processes. However, our data indicate that SPH, which is also a component of the sphingomyelin pathway,60'61 might be important in Ca>2 signaling and contractility, especially in muscle cells. Moreover, in muscle, SPH may be more important in this regard than other components of the signal transduction pathway, such as ceramide.
In conclusion, the present data indicate that the second messenger, SPH, is capable of strongly influencing intracellular Ca2+ levels in cardiac ventricular myocytes. This effect may be due to the inhibition by SPH of both Ca>2 entry through the voltage-dependent Ca>2 channel and its inhibition of CICR. Since SPH is endogenous to the cardiac cell, we propose that it may be an important second messenger, which when generated by cytokines, growth factors, or other stimuli, could influence cardiac contractility. Since SPH is likely produced in the same location (ie, the T tubule) where the DPHR is located, it is possible that SPH is a natural ligand for the DHPR. We are currently investigating this possibility in our laboratories.
